Physician profile
Robert D Beasley
NPI 1992717268
$1,447.72
in general payments reported to CMS, 2019-2025
13 companies · $430 in 2025
The $430 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $63.12 · 2021: $768 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $429.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Veryan Medical Incorporated | $768.25 | 2021 | |
| Asahi Intecc USA, INC. | $109.80 | 2025 | Asahi Peripheral Vascular Wires |
| Sanofi-Aventis U.S. LLC | $107.34 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.00 | 2019 | |
| Exact Sciences Corporation | $62.96 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals Lp | $59.96 | 2019-2025 | Airsupra |
| Glaxosmithkline, LLC. | $49.80 | 2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Lilly USA, LLC | $42.51 | 2025 | Zepbound, Mounjaro |
| Pfizer INC. | $36.99 | 2025 | |
| Amgen INC. | $35.80 | 2025 | Prolia, Evenity, Otezla |
| Inspire Medical Systems, INC. | $32.78 | 2025 | Inspire |
| Abbvie INC. | $23.23 | 2025 | |
| Novo Nordisk INC | $18.30 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Beasley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.